Pet dogs set to test anti-ageing drug Nature.com Their target is rapamycin, which is used clinically as part of an anti-rejection drug cocktail after kidney transplants and which has also been shown to extend the lives of mice by 13% in females and 9% in males (D. E. Harrison et al. Nature 460, 392 ... |
No comments:
Post a Comment